共 4 条
[1]
Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer[J] Nancy U.Lin;ElizabethClaus;JessicaSohl;Abdul R.Razzak;AmalArnaout;Eric P.Winer Cancer 2008,
[2]
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer[J] Edurne Arriola;Socorro Maria Rodriguez-Pinilla;Maryou B. K. Lambros;Robin L. Jones;Michelle James;Kay Savage;Ian E. Smith;Mitch Dowsett;Jorge S. Reis-Filho Breast Cancer Research and Treatment 2007,
[3]
Tamoxifen for early breast cancer: an overview of the randomised trials[J] The Lancet 1998,
[4]
Estrogen-dependent; tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu[J] Christopher C. Benz;Gary K. Scott;Jay C. Sarup;Randolph M. Johnson;Debasish Tripathy;Ester Coronado;H. Michael Shepard;C. Kent Osborne Breast Cancer Research and Treatment 1992,